Clinical Trials Browser

Phase NA × Nasopharyngeal Neoplasms × Gemcitabine × Clear all

NCT02627807 2020-06-16

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Phase NA Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms